Skip to main content
Top
Published in: BMC Neurology 1/2006

Open Access 01-12-2006 | Research article

Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration

Authors: Barbara Borroni, Daniela Perani, Silvana Archetti, Chiara Agosti, Barbara Paghera, Giuseppe Bellelli, Monica Di Luca, Alessandro Padovani

Published in: BMC Neurology | Issue 1/2006

Login to get access

Abstract

Background

It has been recently demonstrated that in Frontotemporal Lobar Degeneration (FTLD) memory deficits at presentation are commoner than previously thought. Apolipoprotein E (ApoE) genotype, the major genetic risk factor in sporadic late-onset Alzheimer Disease (AD), modulates cerebral perfusion in late middle-age cognitively normal subjects. ApoE ε4 homozygous have reduced glucose metabolism in the same regions involved in AD.
The aim of this study was to determine whether ApoE genotype might play a key-role in influencing the cerebral functional pattern as well as the degree of memory deficits in FTLD patients.

Methods

Fifty-two unrelated FTLD patients entered the study and underwent a somatic and neurological evaluation, laboratory examinations, a brain structural imaging study, and a brain functional Single Photon Emission Tomography study. ApoE genotype was determined.

Results

ApoE genotype influenced both clinical and functional features in FTLD. ApoE ε4-carriers were more impaired in long-term memory function (ApoE ε4 vs. ApoE non ε4, 6.3 ± 3.9 vs. 10.1 ± 4.2, p = 0.004) and more hypoperfused in uncus and parahippocampal regions (x,y,z = 38,-6,-20, T = 2.82, cluster size = 100 voxels; -32,-12,-28, T= 2.77, cluster size = 40 voxels).

Conclusion

The present findings support the view that ApoE genotype might be considered a disease-modifying factor in FTLD, thus contributing to define a specific clinical presentation, and might be of relevance for pharmacological approaches.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kertesz A, Munoz DG: Pick's disease and Pick complex. 1998, Wiley-Liss, New York Kertesz A, Munoz DG: Pick's disease and Pick complex. 1998, Wiley-Liss, New York
2.
go back to reference Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J: Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005, 128: 597-605. 10.1093/brain/awh348.CrossRefPubMed Graham A, Davies R, Xuereb J, Halliday G, Kril J, Creasey H, Graham K, Hodges J: Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005, 128: 597-605. 10.1093/brain/awh348.CrossRefPubMed
3.
go back to reference Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell FTLD, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993, 261: 921-923.CrossRefPubMed Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell FTLD, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993, 261: 921-923.CrossRefPubMed
4.
go back to reference Schott J, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC: Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Arch Neurol. 2006, 63: 157-158. 10.1001/archneur.63.1.155.CrossRef Schott J, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC: Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Arch Neurol. 2006, 63: 157-158. 10.1001/archneur.63.1.155.CrossRef
6.
go back to reference Litvan I, Agid Y, Calne D, Campbell G, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996, 47: 1-9.CrossRefPubMed Litvan I, Agid Y, Calne D, Campbell G, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996, 47: 1-9.CrossRefPubMed
7.
go back to reference Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998, 51: 1546-1554.CrossRefPubMed Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998, 51: 1546-1554.CrossRefPubMed
8.
go back to reference Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-98. 10.1016/0022-3956(75)90026-6.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-98. 10.1016/0022-3956(75)90026-6.CrossRefPubMed
9.
go back to reference Bingham WC, Burke HR, Murray S: Raven's Progressive Matrices: construct validity. J Psycgol. 1966, 62: 205-9. Bingham WC, Burke HR, Murray S: Raven's Progressive Matrices: construct validity. J Psycgol. 1966, 62: 205-9.
10.
go back to reference Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973, 123: 467-470.CrossRefPubMed Isaacs B, Kennie AT: The Set test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973, 123: 467-470.CrossRefPubMed
11.
go back to reference Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS: Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc. 1989, 37: 730-4.CrossRefPubMed Wolf-Klein GP, Silverstone FA, Levy AP, Brod MS: Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc. 1989, 37: 730-4.CrossRefPubMed
12.
go back to reference Loring DW, Martin RC, Meador KJ: Psychometric construnction of the Rey-Osterrieth Complex Figure. Arch Clin Neuropsych. 1990, 5: 1-14. 10.1016/0887-6177(90)90002-7.CrossRef Loring DW, Martin RC, Meador KJ: Psychometric construnction of the Rey-Osterrieth Complex Figure. Arch Clin Neuropsych. 1990, 5: 1-14. 10.1016/0887-6177(90)90002-7.CrossRef
13.
go back to reference Babcock H, Levy L: The measurement of mental efficiency of mental functioning (revised examination). Test and manual of directions. 1940, Chicago: CH Stoelting Babcock H, Levy L: The measurement of mental efficiency of mental functioning (revised examination). Test and manual of directions. 1940, Chicago: CH Stoelting
14.
go back to reference Blackburn HL, Benton AL: Revised administration and scoring of the digit span test. J Consult Psychol. 1957, 21: 139-43. 10.1037/h0047235.CrossRefPubMed Blackburn HL, Benton AL: Revised administration and scoring of the digit span test. J Consult Psychol. 1957, 21: 139-43. 10.1037/h0047235.CrossRefPubMed
15.
go back to reference Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and motor skills. 1958, 8: 271-76.CrossRef Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and motor skills. 1958, 8: 271-76.CrossRef
16.
go back to reference De Renzi E, Vignolo LA: The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain. 1962, 85: 665-78.CrossRefPubMed De Renzi E, Vignolo LA: The Token Test: a sensitive test to detect receptive disturbances in aphasics. Brain. 1962, 85: 665-78.CrossRefPubMed
17.
go back to reference De Renzi E, Motti F, Nichelli P: Imitating gestures. A quantitative approach to ideomotor apraxia. Arch Neurol. 1980, 37: 6-10.CrossRefPubMed De Renzi E, Motti F, Nichelli P: Imitating gestures. A quantitative approach to ideomotor apraxia. Arch Neurol. 1980, 37: 6-10.CrossRefPubMed
18.
go back to reference Lawton MP, Broody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist. 1969, 9: 179-186.CrossRefPubMed Lawton MP, Broody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist. 1969, 9: 179-186.CrossRefPubMed
19.
go back to reference Sheikh K, Smith DS, Meade TW, Goldenberg E, Brennan PJ, Kinsella G: Repeatibility and validity of a modified Activities of Daily Living (ADL) Index in studies of chronic disability. Int Rehabil Med. 1979, 1: 51-58.CrossRefPubMed Sheikh K, Smith DS, Meade TW, Goldenberg E, Brennan PJ, Kinsella G: Repeatibility and validity of a modified Activities of Daily Living (ADL) Index in studies of chronic disability. Int Rehabil Med. 1979, 1: 51-58.CrossRefPubMed
20.
go back to reference Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994, 44: 2308-14.CrossRefPubMed Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994, 44: 2308-14.CrossRefPubMed
21.
go back to reference Kertesz A, Nadkarni N, Davidson W, Thomas AW: The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000, 6: 460-8. 10.1017/S1355617700644041.CrossRefPubMed Kertesz A, Nadkarni N, Davidson W, Thomas AW: The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000, 6: 460-8. 10.1017/S1355617700644041.CrossRefPubMed
22.
go back to reference Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A, European Association of Nuclear Medicine: European Association of Nuclear Medicine. European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals. Eur J Nucl Mol Imaging. 2002, 29: BP36-42.CrossRef Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A, European Association of Nuclear Medicine: European Association of Nuclear Medicine. European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals. Eur J Nucl Mol Imaging. 2002, 29: BP36-42.CrossRef
23.
go back to reference Friston KJ: Testing for anatomically specified regional effects. Hum Brain Mapp. 1997, 5: 133-6. 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4.CrossRefPubMed Friston KJ: Testing for anatomically specified regional effects. Hum Brain Mapp. 1997, 5: 133-6. 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4.CrossRefPubMed
24.
go back to reference Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A: MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004, 63: 2332-2340.CrossRefPubMed Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A: MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 2004, 63: 2332-2340.CrossRefPubMed
25.
go back to reference Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allelle of apolipoprotein E. New Eng J Med. 1996, 334: 752-758. 10.1056/NEJM199603213341202.CrossRefPubMed Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allelle of apolipoprotein E. New Eng J Med. 1996, 334: 752-758. 10.1056/NEJM199603213341202.CrossRefPubMed
26.
go back to reference Borroni B, Yancopoulou D, Tsutsui M, Padovani A, Sawcer SJ, Hodges JR, Spillantini MG: Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol. 2005, 62: 1419-1422. 10.1001/archneur.62.9.1419.CrossRefPubMed Borroni B, Yancopoulou D, Tsutsui M, Padovani A, Sawcer SJ, Hodges JR, Spillantini MG: Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol. 2005, 62: 1419-1422. 10.1001/archneur.62.9.1419.CrossRefPubMed
27.
go back to reference Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G: (1997) Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord. 1997, 8: 240-243.CrossRefPubMed Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G: (1997) Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord. 1997, 8: 240-243.CrossRefPubMed
28.
go back to reference Srinivasan R, Davidson Y, Gibbons L, Payton A, Richardson AM, Varma A, Julien C, Stopford C, Thompson J, Horan MA, Pendleton N, Pickering-Brown SM, Neary D, Snowden JS, Mann DM: The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry. 2006, 77: 154-8. 10.1136/jnnp.2005.063966.CrossRefPubMedPubMedCentral Srinivasan R, Davidson Y, Gibbons L, Payton A, Richardson AM, Varma A, Julien C, Stopford C, Thompson J, Horan MA, Pendleton N, Pickering-Brown SM, Neary D, Snowden JS, Mann DM: The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry. 2006, 77: 154-8. 10.1136/jnnp.2005.063966.CrossRefPubMedPubMedCentral
29.
go back to reference Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M: Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol. 2002, 59: 611-5. 10.1001/archneur.59.4.611.CrossRefPubMed Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M: Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol. 2002, 59: 611-5. 10.1001/archneur.59.4.611.CrossRefPubMed
30.
go back to reference Fabre SF, Forsell C, Viitanen M, Sjogren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund LO, Lannfelt L: Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol. 2001, 168: 413-8. 10.1006/exnr.2000.7613.CrossRefPubMed Fabre SF, Forsell C, Viitanen M, Sjogren M, Wallin A, Blennow K, Blomberg M, Andersen C, Wahlund LO, Lannfelt L: Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol. 2001, 168: 413-8. 10.1006/exnr.2000.7613.CrossRefPubMed
31.
go back to reference Geschwind D, Karrim J, Nelson SF, Miller B: The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol. 1998, 44: 134-8. 10.1002/ana.410440122.CrossRefPubMed Geschwind D, Karrim J, Nelson SF, Miller B: The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol. 1998, 44: 134-8. 10.1002/ana.410440122.CrossRefPubMed
Metadata
Title
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration
Authors
Barbara Borroni
Daniela Perani
Silvana Archetti
Chiara Agosti
Barbara Paghera
Giuseppe Bellelli
Monica Di Luca
Alessandro Padovani
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2006
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-6-31

Other articles of this Issue 1/2006

BMC Neurology 1/2006 Go to the issue